InvestorsHub Logo
Followers 2
Posts 34
Boards Moderated 1
Alias Born 07/14/2015

Re: None

Tuesday, 04/11/2017 11:06:38 AM

Tuesday, April 11, 2017 11:06:38 AM

Post# of 2029
A new path to pain relief. Time for change with a peripherally acting Kappa Opioid Receptor Against (KORA)! Cara's chief medical officer Dr Joseph Stauffer presents clinical trial data for CR845 in the treatment of acute and chronic pain this May at the 17th annual industry summit on Pain Therapeutics. http://www.pain-therapeutics.co.uk/ihub
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent CARA News